| scholarly article | Q13442814 |
| P2093 | author name string | Robert M Strieter | |
| Michael P Keane | |||
| P2860 | cites work | ??? | Q28215495 |
| Chemokine receptor responses on T cells are achieved through regulation of both receptor expression and signaling | Q22009382 | ||
| Regulation of pulmonary fibrosis by chemokine receptor CXCR3 | Q24563456 | ||
| The chemokine receptors CXCR3 and CCR5 mark subsets of T cells associated with certain inflammatory reactions | Q24564834 | ||
| Interferon-γ: an overview of signals, mechanisms and functions | Q28207081 | ||
| Mig and IP-10: CXC chemokines that target lymphocytes | Q28305342 | ||
| Gene expression analysis reveals matrilysin as a key regulator of pulmonary fibrosis in mice and humans | Q34028910 | ||
| Idiopathic pulmonary fibrosis: clinical relevance of pathologic classification | Q34066372 | ||
| The prognosis of idiopathic pulmonary fibrosis | Q35540561 | ||
| A preliminary study of long-term treatment with interferon gamma-1b and low-dose prednisolone in patients with idiopathic pulmonary fibrosis | Q40631272 | ||
| Diffuse lung disease: a view for the future. | Q40901487 | ||
| Effects of interferon-gamma 1b on biomarker expression in patients with idiopathic pulmonary fibrosis | Q46724355 | ||
| Radiologic findings are strongly associated with a pathologic diagnosis of usual interstitial pneumonia | Q47446738 | ||
| A placebo-controlled trial of interferon gamma-1b in patients with idiopathic pulmonary fibrosis | Q48033849 | ||
| The epidemiology of interstitial lung diseases | Q72705569 | ||
| American Thoracic Society. Idiopathic pulmonary fibrosis: diagnosis and treatment. International consensus statement. American Thoracic Society (ATS), and the European Respiratory Society (ERS) | Q73445075 | ||
| Lymphocyte-specific chemokine receptor CXCR3: regulation, chemokine binding and gene localization | Q77647010 | ||
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | pulmonary fibrosis | Q32446 |
| P304 | page(s) | 165-168 | |
| P577 | publication date | 2004-07-01 | |
| P1433 | published in | Journal of Clinical Investigation | Q3186904 |
| P1476 | title | Innate immunity dictates cytokine polarization relevant to the development of pulmonary fibrosis | |
| P478 | volume | 114 |
| Q24811707 | CD8+ T lymphocytes in lung tissue from patients with idiopathic pulmonary fibrosis |
| Q44572411 | CXCR3-/- mice mount an efficient Th1 response but fail to control Leishmania major infection |
| Q46145178 | Decreased survival of guinea pigs infected with Mycobacterium tuberculosis after multiple BCG vaccinations |
| Q90720617 | Development and Progression of Non-Alcoholic Fatty Liver Disease: The Role of Advanced Glycation End Products |
| Q24546358 | Galectin-3 regulates myofibroblast activation and hepatic fibrosis |
| Q37957865 | Inflammatory mechanisms in the lung. |
| Q25257003 | Interleukin-12 is not essential for silicosis in mice |
| Q36849440 | Maintenance of radiation-induced intestinal fibrosis: cellular and molecular features |
| Q37418946 | Mechanisms of over-activated innate immune system regulation in autoimmune and neurodegenerative disorders |
| Q34963371 | Meta-analysis of genetic programs between idiopathic pulmonary fibrosis and sarcoidosis |
| Q35035078 | Natural killer cells from patients with chronic rhinosinusitis have impaired effector functions |
| Q47727059 | Natural killer cells in Bal and peripheral blood of patients with idiopathic pulmonary fibrosis (IPF). |
| Q28391714 | Natural killer cells in infection and inflammation of the lung |
| Q38639439 | Protective role of NKT cells and macrophage M2-driven phenotype in bleomycin-induced pulmonary fibrosis |
| Q43188588 | Pulmonary hypertension is ameliorated in mice deficient in thrombin-activatable fibrinolysis inhibitor. |
| Q37800756 | The pathogenesis of idiopathic pulmonary fibrosis. |
| Q37811063 | Transgenic modelling of cytokine polarization in the lung |
Search more.